Multiple Sclerosis and Aging

Multiple sclerosis (MS) is the most common chronic inflammatory disease of the central nervous system which is characterized by inflammatory demyelination and neurodegeneration. Here is the latest research MS and aging.

May 7, 2020
Open Access

Multiple sclerosis and related challenges to young women's health: Canadian expert review

Neurodegenerative Disease Management
Galina VorobeychikAshley Cox
November 27, 2019

1,25(OH)2 D3 in Brain Function and Neuropsychiatric Disease

Neuro-Signals
Florian LangChristina B Leibrock
February 13, 2020

Association between shorter leukocyte telomeres and multiple sclerosis

Journal of Neuroimmunology
Raneem HabibLarissa Arning
December 25, 2019
Review
Open Access

Lipid rafts and neurodegeneration: structural and functional roles in physiologic aging and neurodegenerative diseases

Journal of Lipid Research
Sara GrassiAlessandro Prinetti
May 29, 2020
Preprint
Open Access

Extensive Healthy Donor Age/Gender Adjustments and Propensity Score Matching Reveal Physiology of Multiple Sclerosis through Immunophenotyping

MedRxiv : the Preprint Server for Health Sciences
P. HannikainenBibiana Bielekova
June 2, 2020

A Systematic Review of the Neurocognitive Effects of Cannabis Use in Older Adults

Current Addiction Reports
Emmi P ScottAndreana Benitez
June 27, 2020
Preprint

Fast automatic segmentation of thalamic nuclei from MP2RAGE acquisition at 7 Tesla

ArXiv
Ritobrato DattaManojkumar Saranathan
June 23, 2020

Hippocampal volume is more related to patient-reported memory than objective memory performance in early multiple sclerosis

Multiple Sclerosis : Clinical and Laboratory Research
Lisa GlukhovskyJames F Sumowski
May 28, 2020
Review

Impact of Age on Multiple Sclerosis Disease Activity and Progression

Current Neurology and Neuroscience Reports
Burcu Zeydan, Orhun H Kantarci
June 25, 2020
Review

Family planning in multiple sclerosis: conception, pregnancy, breastfeeding

Ideggyógyászati szemle
Csilla Rózsa
November 23, 2019
Review

Urological function and dysfunction in aging: Diagnosis and treatment

Handbook of Clinical Neurology
Theodore M Johnson, Camille P Vaughan
April 25, 2020

Contribution of normal aging to brain atrophy in MS

Neurology. Neuroimmunology and Neuroinflammation
Christina J AzevedoDaniel Pelletier
May 12, 2020
Open Access

Shared Regulatory Pathways Reveal Novel Genetic Correlations Between Grip Strength and Neuromuscular Disorders

Frontiers in Genetics
Sreemol GokuladhasJustin O'Sullivan
February 11, 2020
Open Access

Bacterial Immunogenicity Is Critical for the Induction of Regulatory B Cells in Suppressing Inflammatory Immune Responses

Frontiers in Immunology
Jan Kevin MaerzJulia-Stefanie Frick

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

© 2020 Meta ULC. All rights reserved
/feed-previews/multiple-sclerosis-and-aging/cce082e1-73b4-435d-b61a-42ded6bef250